These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3895913)

  • 21. Treatment of skin, skin structure, bone, and joint infections with ceftazidime.
    Gentry LO
    Am J Med; 1985 Aug; 79(2A):67-74. PubMed ID: 3895921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: Monotherapy with ceftazidime and tobramycin combined with amoxycillin/ampicillin].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Wieczorek M; Janik-Moszant A; Kuder K
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):417-20. PubMed ID: 2267192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].
    de Pauw BE
    Infection; 1987; 15 Suppl 4():S168-72. PubMed ID: 3312029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R; DePauw B; Berman S; Keating A; Ho W
    J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
    Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
    J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
    d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
    J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients.
    Dranitsaris G; Tran TM; McGeer A; Narine L
    Pharmacoeconomics; 1995 Jan; 7(1):49-62. PubMed ID: 10155293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR; Finch RG; Glauser M
    J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
    Schaison G; Leverger G; Pappo M; Chiche D
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
    Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
    Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
    Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    Marie JP; Vekhoff A; Pico JL; Guy H; Andremont A; Richet H
    J Antimicrob Chemother; 1998 Jun; 41 Suppl D():57-64. PubMed ID: 9688452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
    Gasparini G; Benedetti M; Fassio T; Canobbio L; Figoli F; Galligioni E; Talamini R; Toffoli G; Tumolo S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):113-20. PubMed ID: 3549581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftazidime in pediatric infections unsuccessfully treated with other antibiotics: an evaluation of its efficacy and tolerability in compromised host.
    Boner AL; Castellani C; Fostini R; Padovani E
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):333-6. PubMed ID: 2942496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
    J Antimicrob Chemother; 1995 Jul; 36(1):185-200. PubMed ID: 8537265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Rains CP; Bryson HM; Peters DH
    Drugs; 1995 Apr; 49(4):577-617. PubMed ID: 7789291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.